Role of vascular nitric oxide in experimental liver cirrhosis

Current Vascular Pharmacology

Volumn 3, Issue 1, 2005, Pages 81-85

  Atucha, Noemí M ^a   Nadal, F Javi A ^a   Iyú, David ^a   Alcaraz, Antonia ^a   Rodríguez Barbero, Alicia ^a   Ortiz, M Clara ^a   López Novoa, José Miguel ^a   García Estañ, Joaquín ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Endothelium; Liver cirrhosis; Nitric oxide; Portal hypertension; Smooth muscle cells; Vasoconstrictors; Vasodilation

Indexed keywords

NITRIC OXIDE;

ANIMAL MODEL; ARTERY DILATATION; BLOOD VESSEL REACTIVITY; CALCIUM TRANSPORT; ENDOTHELIUM; EXPERIMENTAL MODEL; EXTRACELLULAR SPACE; LIVER CIRRHOSIS; NONHUMAN; PRESSOR RESPONSE; REVIEW; SMOOTH MUSCLE CONTRACTILITY; VASCULAR CAPACITY;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; LIVER CIRRHOSIS, EXPERIMENTAL; METHODS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; SPAIN;

EID: 11844292021     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570161052773889     Document Type: Review

References (44)

1. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-666.
2. Ignarro LJ. Nitric oxide, a novel signal transduction mechanism for transcellular communication. Hypertension 1990;16:477-483.
3. Romero JC, Garcia-Estañ J, Atucha NM. Nitric oxide and renal function: The control of blood pressure under normal conditions and during cirrhosis. In "The kidney in liver disease", M Epstein, ed., 4th ed., Hanley & Belfus, Inc., Philadelphia, 373-385, 1996.
4. López-Novoa JM. Pathophysiological features of the carbon tetrachloride/ phenobarbital model of experimental liver cirrhosis in rats. In: The kidney in liver disease. M. Epstein Ed; William and Wilkins, Baltimore, 1988, pp 309-324.
5. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 5: 1151-1157.
6. Clària J, Jiménez W, Ros J, Asbert M, Castro A, Arroyo V, et al. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 1992; 15:343-349.
7. Pizcueta MP, Piqué JM, Bosch J, Whittle BJR, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992; 105:184-190.
8. Pizcueta MP, Piqué JM, Fernández M, Bosch J, Rodés J, Whittle BJR, et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103: 1909-1915.
9. w-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology 1993; 17:84-90.
10. Niederberger M, Martin P, Ginds P, Morris K, Tsai P. Xu D, et al. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 109:1624-1630, 1995.
11. Wiest R, Shah V, Sessa WC, Groszmann RJ. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol 1999; 276: G1043-G1051.
12. Lee FJ, Wang SS, Tsai YT, Lin HJ, Lin HC, Chu CJ, et al. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anaesthetised portal hypertensive rats. J Hepatol 1997; 26: 687-693.
13. Murray BM, Paller MS. Decreased pressor reactivity to angiotensin II in cirrhotic rats. Circ Res 1985; 57: 424-431.
14. Murray BM, Paller MS. Pressor resistance to vasopressin in sodium depletion, potassium depletion and cirrhosis. Am J Physiol 1986; 251: R525-R530.
15. Hartleb M, Moreau R, Cailmail S, Gaudin C, Lebrec D. Vascular hyporesponsiveness to endothelin-1 in rats with cirrhosis. Gastroenterology 1994; 107:1085-1093.
16. Obbergh LV, Leonard V, Chen H, Xu D, Blaise G. The endothelial and non-endothelial mechanism responsible for attenuated vasoconstriction in cirrhotic rats. Exp Physiol 1995; 80: 609-617.
17. Ortiz MC, Fortepiani LA, Martínez C, Atucha NM, García-Estañ, J. Vascular hyporesponsiveness in aortic rings from cirrhotic rats: role of nitric oxide and endothelium. Clin Sci 1996; 91: 733-738.
18. Safka V, Moreau R, Gadano A, Lebrec D. Vascular hyporesponsiveness to vasodilators in rats with cirrhosis. J Hepatol 1997; 26:382-386.
19. Lee SS, Pak J-M, Medlicott SM, Bomzon A. Vasodilatory responses of isolated arteries of cirrhotic rats. Clin Sci 1995; 89: 227-232.
20. Lee FY, Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology 1992; 16; 1043-1048.
21. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992; 103; 235-239.
22. Heinemann A, Stauber RE. The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats. Eur J Pharmacol 1995; 278:87-90.
23. Sogni P, Sabry S, Moreau R, Gadano A, Lebrec L, Dinh-Xuan AT. Hyporeactivity of mesenteric arteries in portal hypertensive rats. J Hepatol 1996; 24: 487-490.
24. Atucha NM, Shah V, García-Cardeña G, Sessa WE, Groszmann RJ. Role of the endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis. Gastroenterology 1996; 111: 1627-1632.
25. Atucha NM, Ortiz MC, Martínez C, Quesada T, García-Estañ J. Role of protein kinase C in mesenteric pressor responses of rats with portal hypertension. Br J Pharmacol 1996; 118:277-282.
26. Heinemann A, Wachter CH, Holzer P, Fickert P, Stauber RE. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats. Br J Pharmacol 1997; 121: 1031-1037.
27. Atucha NM, Ortiz MC, Fortepiani LA, Ruiz FM, Martínez C, García-Estañ J. Role of cyclic GMP and potassium channels as mediators of the mesenteric vascular hyporesponsiveness in portal hypertensive rats. Hepatology 1998; 27: 900-905.
28. Cahill PA, Foster C, Redmond EM, Gingalewski C, Wu Y, Sitzmann JV. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology 1995; 22:598-606.
29. Niederberger M, Ginès P, Martin P-Y, Tsai P, Morris K, McMurtry I, et al. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 1996; 24: 947-951.
30. Hori N, Wiest R, Groszmann RJ. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats. Hepatology 1998; 28: 1467-1473.
31. Karatapanis S, McCormick PA, Kakad S, Chin JK, Islam M, Jeremy J, et al. Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats. Hepatology 1994; 20: 1516-1521.
32. Michielsen PP, Boeckxstaens, Sys SU, Herman AG, Pelckmans PA. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats. J Hepatol 1995; 23:341-347.
33. Michielsen PP, Boeckxstaens, Sys SU, Herman AG, Pelckmans PA. Role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats. Eur J Pharmacol 1995; 273: 167-174.
34. Connolly C, Cawley T, McCormick A, Docherty JR. Portal hypertension increases vasoconstrictor responsiveness of rat aorta. Clin Sci 1999; 96: 41-47.
35. Fernandez Muñoz, MD., Villamediana, LM., Blanchart A, Caramelo C, Hernando L, López-Novoa JM. Hemodynamic effects of angiotensin II in conscious, non ascitic, cirrhotic rats. Clin Physiol Biochem 1988; 6:36-43.
36. Villamediana LM, Dieguez G, Santos JC, Garcia Villalón AL, Caramelo C, López-Novoa JM. Vascular reactivity to norepinephrine in rats with cirrhosis of the liver. Can J Physiol Pharmacol 1988; 66:567-572.
37. Sieber CC, López-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993; 104: 1750-1754.
38. + channels. Clin Sci 2000; 99: 455-460.
39. García-Estañ J, Atucha NM, Sabio JM, Vargas F, Quesada T, Romero JC. Increased endothelium-dependent renal vasodilation in cirrhotic rats. Am J Physiol 1994; 267: R549-R553.
40. Clària J, Jiménez W, Ros J, Rigol M, Angeli P, Arroyo V, et al. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology 1994; 20: 1615-1621.
41. Ros J, Jiménez W, Lamas S, Clària J, Arroyo V, Rivera F, et al. Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology 1995; 21:554-560.
42. Weigert AL, Martin P-Y, Niederberger M, Higa EMS, McMurtry IF, Schrier RW. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats. Hepatology 1995; 22: 1856-1862.
43. Nadal FJA, Iyu D, Atucha NM, García-Estañ J. Interaction of nitric oxide with calcium in the mesenteric bed of bile duct-ligated rats. Br J Pharmacol 2002; 135: 489-495.
44. Atucha NM, Iyu D, De Rycker M, Soler A, García-Estañ J. Altered calcium regulation in freshly isolated aortic smooth muscle cells from bile duct-ligated rats: Role of nitric oxide. Cell Calcium 2003; 33:129-135.